Navigation Links
Symmetry Medical to Expand Malaysian Operations
Date:2/26/2008

- Company to Increase Manufacturing and Design and Development Capabilities

to Support Asian Market -

WARSAW, Ind., Feb. 26 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), an independent provider of products to the global orthopedic device industry and other medical markets, announced today that it plans to invest $20 million over the next three years to expand its Malaysian operations by increasing manufacturing and design and development capabilities. The majority of the $20 million investment will occur by year end 2009.

Symmetry will move its existing case facility to a larger, new 50,000 square foot facility on Penang Island which will enable instrument production and implant finishing to be established. This facility will also house the regional design and development center together with a regional logistics operation.

A five acre site with the option to purchase an additional five acres has also been obtained by the Company on the Penang Science Park to build a dedicated forging operation. The site will have spare land that will enable future growth to be accommodated as the regional operation develops.

Brian Moore, President and Chief Executive Officer, stated, "We are very pleased with the progress that we have made on our Asia strategy. These investments in our Malaysian operations are consistent with our strategy of building a full service facility, capable of bringing our Total Solutions(R) business model to the Asian market by the end of 2009. We believe our current customers with locations in Asia will take full advantage of our increased capabilities. We have also begun to generate new customer relationships in the region as a result of our presence and expanding capabilities and look forward to further progress growing our presence."

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s business, which are not historical facts, may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," "anticipates," "plans" and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual results could differ materially from our current expectations. Certain factors that could cause actual results to differ include: the loss of one or more customers; the development of new products or product innovations by our competitors; product liability; changes in management; changes in conditions effecting the economy, orthopedic device manufacturers or the medical device industry generally; and changes in government regulation of medical devices and third-party reimbursement practices. We refer you to the "Risk Factors" and "Forward Looking Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC, which are available on the SEC's Web site at http://www.sec.gov.

Investors/Media: Contact:

The Ruth Group Symmetry Medical Inc.

Nick Laudico/Jason Rando Fred L. Hite

(646) 536-7030/7025 Senior Vice President

nlaudico@theruthgroup.com Chief Financial Officer

jrando@theruthgroup.com (574) 371-2218


'/>"/>
SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Facial asymmetry persists despite surgery to correct congenital deformity
2. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
3. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
4. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
5. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
6. Symmetry Medical Launches New Global Web site
7. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
8. KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director
9. WallSt.net (www.wallst.net) Updates Investment Community Through All-New Interview With digiMedical Solutions
10. MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System
11. SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... leadership , media relations, content marketing, social media management, corporate communications, SEO and ... in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism and ... for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. ... to see films in an environment that accommodates their unique needs. , Launched ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/24/2017)... Australia , Feb. 23, 2017  Directors from Pharma To ... two companies have joined forces, resulting in the founding of Pharma ... Pharma To Market are pleased to announce their expansion ... office in Singapore . The company are delighted ... as Co-Director of the Singapore based entity. ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
Breaking Medicine Technology: